Sensory Attention Focused Exercise in Parkinson's Disease

Sun Life Financial Movement Disorders Research and Rehabilitation Centre

Status: Unknown

Conditions: Parkinson's Disease

Treatments: Other: Sensory Attention Focused Exercise (SAFEx)

Study type: Interventional

Funder types: Other

Identifiers

NCT01246700

225510

Details and patient eligibility

About

The purpose of this study is 1.) to determine if sensory attention focused exercise is an effective management strategy for Parkinson's disease, and 2.) to identify if the benefits are a result of strength gains.

Full description

Currently, there is no cure for Parkinson's disease (PD) and although medication offers symptom reduction, there are many negative side effects associated with medication use. Thus, there has been an increased emphasis on exercise interventions for symptom reduction. Recent research has shown that both sensory attention focused exercise (SAFEx) and strength training interventions improved disease severity more so than other exercise interventions (such as aerobic, aquatic and no exercise). Upon closer examination, SAFEx showed further symptom improvements than the strength training program. Thus exists the need to further examine SAFEx using a standardized protocol - a single-blind randomized double-crossover trial - that has been used sparingly in exercise interventions. In addition, the 30-second chair stand has been implemented into the testing protocol, as it has been shown to be a reliable measurement of functional strength for older adults. This test was implemented in order to identify the functional strength gains, if any, that are associated with SAFEx. It is hypothesized that the SAFEx intervention will improve disease symptoms in PD, and that the results will not be due to strength gains.

Enrollment: 76 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• diagnosis of PD by a clinician/neurologist
• absence of mentation
• established medication schedule and dosage

Exclusion criteria

• mentation
• change in medication during period of study
• change in exercise level during period of study
• inability to complete the exercise program
• absence of 5 or more classes, or absence of 3 or more classes in sequence

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind

---

76 participants in 2 patient groups

Group A

Experimental group

Description:

Participants received 12 weeks of Sensory Attention Focused Exercise, then received 12 weeks of no exercise.

Treatment:

Other: Sensory Attention Focused Exercise (SAFEx)

Other: Sensory Attention Focused Exercise (SAFEx)

Group B

Experimental group

Description:

Participants received no treatment for 12 weeks, then received Sensory Attention Focused Exercise for 12 weeks.

Treatment:

Other: Sensory Attention Focused Exercise (SAFEx)

Other: Sensory Attention Focused Exercise (SAFEx)